Outsourcing

Articles

Purisys is now certified for ISO 17025 for testing and calibration laboratories and ISO 17034 for reference material producers

Purisys Adds ISO Certifications 

Centrient started production at its new statins API manufacturing unit in Toansa, India.

Centrient Pharmaceuticals Adds API Capacity

Through the acquisition, Aceto can now offer its customers support throughout the drug development process and access to North American manufacturing for APIs and advanced intermediates.

Aceto to Acquire Cascade Chemistry

The companies are expanding their collaboration to extend the drug substance manufacturing of Moderna’s COVID-19 vaccine with the addition of a new manufacturing line at Lonza’s Geleen, Netherlands, site. 

Lonza and Moderna to Expand Their COVID-19 Vaccine Drug Substance Manufacturing Collaboration

Expected to be completed by 2022, the new addition is part of the Samsung Biologics’ long-term strategy to become a fully integrated global biopharmaceutical company.

Samsung Biologics to Add mRNA Capabilities to South Korea Facility 

Colorcon’s new suite will provide clients with capabilities to develop prototype tablets or capsule dosage forms when API quantity is limited or the API potency requires a higher level of protection.

Colorcon to Expand its Technical Capabilities with New Containment Suite at its Pennsylvania Headquarters

Moderna’s investments will double the formulation fill/finish and drug substance manufacturing of its vaccine to up to three billion doses in 2022 at various manufacturing sites. 

Moderna Announces Additional Investments to Increase COVID-19 Vaccine Supply for 2022

Catalent’s new mammalian cell culture suites in Madison, Wis. use single-use bioreactor systems for CGMP clinical and commercial manufacturing.

Catalent Completes Expansion of its Biologics Drug Substance Facility in Wisconsin  

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Intensified and distributed manufacturing approaches create flexible, local capacity.

Advanced Manufacturing Technologies Shift Outside the Box

The deal expands Wavelength’s drug substance manufacturing footprint and its API CDMO business.

Contract Manufacturing, Drug Substance, API